Bovie Medical Corporation Stock Upgraded (BVX)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Bovie Medical Corporation (AMEX: BVX) has been upgraded by TheStreet Ratings from sell to hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:

This stock has managed to rise its share value by 38.51% over the past twelve months. Regarding the stock's future course, our hold rating indicates that we do not recommend additional investment in this stock despite its gains in the past year.

Despite its growing revenue, the company underperformed as compared with the industry average of 8.3%. Since the same quarter one year prior, revenues slightly increased by 6.6%. This growth in revenue does not appear to have trickled down to the company's bottom line, displaying stagnant earnings per share.

BOVIE MEDICAL CORP has shown no change in earnings for its most recently reported quarter when compared with the same quarter a year earlier. This company has not demonstrated a clear trend in earnings over the past two years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, BOVIE MEDICAL CORP turned its bottom line around by earning $0.00 versus -$0.09 in the prior year.

The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, BOVIE MEDICAL CORP's return on equity significantly trails that of both the industry average and the S&P 500.

Net operating cash flow has significantly decreased to -$0.30 million or 316.66% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.

.

Bovie Medical Corporation develops, manufactures, and markets medical products and devices with an emphasis on electrosurgical generators and electrosurgical disposables in the United States, Canada, and internationally. Bovie Medical has a market cap of $58.7 million and is part of the health care sector and health services industry. Shares are up 54.5% year to date as of the close of trading on Tuesday.

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.